Related references
Note: Only part of the references are listed.Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection
Alex K. Bryant et al.
AIDS (2017)
Soluble CD163 predicts incident chronic lung, kidney and liver disease in HIV infection
Ditte M. Kirkegaard-Klitbo et al.
AIDS (2017)
Classical and alternative macrophages have impaired function during acute and chronic HIV-1 infection
Leonardo J. Galvao-Lima et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2017)
Identification of promising plasma immune biomarkers to differentiate active pulmonary tuberculosis
Fabiana A. Zambuzi et al.
CYTOKINE (2016)
HIV infection: focus on the innate immune cells
Milena S. Espindola et al.
IMMUNOLOGIC RESEARCH (2016)
Soluble CD163 and Clinical Outcomes in Treated HIV Infection: Insights Into Mechanisms
Peter W. Hunt
JOURNAL OF INFECTIOUS DISEASES (2016)
Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals
Troels Bygum Knudsen et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
ROS-Mediated DNA Methylation Pattern Alterations in Carcinogenesis
Qihan Wu et al.
CURRENT DRUG TARGETS (2015)
Epigenetic Regulation of Inflammatory Cytokines and Associated Genes in Human Malignancies
Rehana Yasmin et al.
MEDIATORS OF INFLAMMATION (2015)
Identification of acetyltransferase genes (HAT1 and KAT8) regulating HBV replication by RNAi screening
Hui Wang et al.
CELL AND BIOSCIENCE (2015)
Mechanisms of Superoxide Signaling in Epigenetic Processes: Relation to Aging and Cancer
Igor Afanas'ev
AGING AND DISEASE (2015)
Dysregulated Immune Activation in Second-Line HAART HIV plus Patients Is Similar to That of Untreated Patients
Milena S. Espindola et al.
PLOS ONE (2015)
Monocyte-Activation Phenotypes Are Associated With Biomarkers of Inflammation and Coagulation in Chronic HIV Infection
Eleanor M. P. Wilson et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Soluble Markers of Inflammation and Coagulation but Not T-Cell Activation Predict Non-AIDS-Defining Morbid Events During Suppressive Antiretroviral Treatment
Allan R. Tenorio et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection
Peter W. Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Aging and HIV/AIDS: pathogenetic role of therapeutic side effects
Rebecca A. Torres et al.
LABORATORY INVESTIGATION (2014)
The Immunomodulatory Nutritional Intervention NR100157 Reduced CD4+ T-Cell Decline and Immune Activation: A 1-Year Multicenter Randomized Controlled Double-Blind Trial in HIV-Infected Persons Not Receiving Antiretroviral Therapy (The BITE Study)
P. Cahn et al.
CLINICAL INFECTIOUS DISEASES (2013)
Effects of treatment with histone deacetylase inhibitors in solid tumors: a review based on 30 clinical trials
Tianzhu Qiu et al.
FUTURE ONCOLOGY (2013)
Systemic Effects of Inflammation on Health during Chronic HIV Infection
Steven G. Deeks et al.
IMMUNITY (2013)
Epigenetics in sepsis: targeting histone deacetylases
Eleonora Ciarlo et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Aspirin Attenuates Platelet Activation and Immune Activation in HIV-1-Infected Subjects on Antiretroviral Therapy: A Pilot Study
Meagan O'Brien et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques
Nichole R. Klatt et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The end of AIDS: HIV infection as a chronic disease
Steven G. Deeks et al.
LANCET (2013)
Transcriptome analysis of primary monocytes from HIV-positive patients with differential responses to antiretroviral therapy
Jing Qin Wu et al.
VIROLOGY JOURNAL (2013)
Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management
Allen S. Ho et al.
ONCOTARGETS AND THERAPY (2013)
SAHA, an HDAC inhibitor, synergizes with tacrolimus to prevent murine cardiac allograft rejection
Xin Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2012)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
N. M. Archin et al.
NATURE (2012)
Intensification of Antiretroviral Therapy With Raltegravir or Addition of Hyperimmune Bovine Colostrum in HIV-Infected Patients With Suboptimal CD4+ T-Cell Response: A Randomized Controlled Trial
Helen Byakwaga et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Valganciclovir Reduces T Cell Activation in HIV-infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy
Peter W. Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
High Dose Atorvastatin Decreases Cellular Markers of Immune Activation Without Affecting HIV-1 RNA Levels: Results of a Double-blind Randomized Placebo Controlled Clinical Trial
Anuradha Ganesan et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the COPA pilot randomized trial
A. Gori et al.
MUCOSAL IMMUNOLOGY (2011)
Association between Use of HMG CoA Reductase Inhibitors and Mortality in HIV-Infected Patients
Richard D. Moore et al.
PLOS ONE (2011)
Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection
Emily S. Ford et al.
AIDS (2010)
Effects of In Vitro HIV-1 Infection on Mycobacterial Growth in Peripheral Blood Monocyte-Derived Macrophages
Sharad Pathak et al.
INFECTION AND IMMUNITY (2010)
Epigenetic modulation of host: new insights into immune evasion by viruses
Dwaipayan Adhya et al.
JOURNAL OF BIOSCIENCES (2010)
Functions of Tat: the versatile protein of human immunodeficiency virus type 1
Bizhan Romani et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Early Immune Senescence in HIV Disease
Seema Desai et al.
Current HIV/AIDS Reports (2010)
Relationship Between a Frailty-Related Phenotype and Progressive Deterioration of the Immune System in HIV-Infected Men
Loic Desquilbet et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages
George B. Kyei et al.
JOURNAL OF CELL BIOLOGY (2009)
Effect of the immunosuppressant histone deacetylase inhibitor FR276457 in a canine renal transplant model
Fumitaka Kinugasa et al.
TRANSPLANT IMMUNOLOGY (2009)
The mechanism underlying defective Fcγ receptor-mediated phagocytosis by HIV-1-infected human monocyte-derived macrophages
Edwin Leeansyah et al.
JOURNAL OF IMMUNOLOGY (2007)
Impaired complement-mediated phagocytosis by HIV type-1-infected human monocyte-derived macrophages involves a cAMP-dependent mechanism
Rula Azzam et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2006)
Immunosuppression by combined use of cyclosporine and resveratrol in a rat liver transplantation model
SL Wu et al.
TRANSPLANTATION PROCEEDINGS (2005)
HIV-1 Nef mediates post-translational down-regulation and redistribution of the mannose receptor
DJ Vigerust et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Cdc42 and RhoB activation are required for mannose receptor-mediated phagocytosis by human alveolar macrophages
JM Zhang et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Statins and blood coagulation
A Undas et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
The HIV-1 Nef protein and phagocyte NADPH oxidase activation
F Vilhardt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
HIV-1 Tat represses transcription from the mannose receptor promoter
RL Caldwell et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
